Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis To Maintain Sales Force In Face Of Potential Competitor Cutbacks

Mar 21 2005

• By The Pink Sheet

Related Content

Zometa, Aredia May Have Different Jaw Osteonecrosis Risk Profiles

Mar 14 2005

Elidel, Protopic “Black Box” Could Be Test Of FDA’s Labeling Authority

Mar 14 2005

Waiting For Pfizer: GSK Will Cut Sales Force Should Pfizer Act First

Feb 14 2005

Pfizer Sales Force Is “Critical” To Five-Year Strategy, McKinnell Says

Jan 24 2005

Novartis Is Rekindling Relationship Sales Model In Mega-Detail World

Dec 16 2002

AstraZeneca Cuts Sales Reps By Reducing PDI Contract; Will Others Follow?

Jan 10 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window